Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
02/2001
02/07/2001EP1073626A1 Azine used as fungicides
02/07/2001CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas
02/06/2001US6184236 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative
01/2001
01/25/2001WO2001005743A1 3-amino-2-benzyl-1-phenyl-propane derivatives
01/25/2001DE19933421A1 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate 2-benzyl-3-dimethylamino-1-phenyl-propanderi- derivatives
01/25/2001CA2378723A1 3-amino-2-benzyl-1-phenyl-propane derivatives
01/24/2001CN1281432A Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing same
01/23/2001US6177576 Pyruvate saccaride ketals
01/23/2001US6177566 Treatment and/or prevention of neuropsychological disorders
01/23/2001US6177400 Improving or modifying the odor of a perfume by adding 4,6,6-trimethyl-1,(3)-cyclohex(adi)ene 1-substituted with esters, ethers or ketones, such as (e)-1-(4,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one
01/23/2001US6177154 Miscibility; low in threshold voltage, induce large pretilt angle, high in voltage holding ratio and are low in its dependency on temperature
01/18/2001CA2378600A1 Amino ceramide-like compounds and therapeutic methods of use
01/17/2001EP1068209A1 Process for the production of purine derivatives and intermediates therefor
01/17/2001EP1068178A1 NON-PEPTIDE GnRH AGENTS
01/17/2001CN1280030A Treating method for waste gas containing dipyryl
01/16/2001US6174711 Method for producing L-allysine acetal
01/16/2001US6174457 Compound having alkadienyl group as side chain, and liquid crystal composition using same
01/11/2001WO2001002463A1 Catalyst composition and use thereof
01/11/2001WO2001002391A2 Bicyclic aromatic compounds for treating drug addiction
01/11/2001DE19931116A1 Verfahren zur Herstellung von Phenethylaminen und neue chemische Verbindungen Process for the preparation of novel chemical compounds and phenethylamines
01/11/2001CA2378389A1 Therapeutic agents
01/10/2001EP1067127A1 Novel beta-diketone compounds, beta-diketone compounds coordinated to metal, method of organic synthesis with these, and catalyst
01/10/2001EP1067113A2 Process for the preparation of phenethylamines and intermediates therefor
01/10/2001EP1066873A1 Process and composition for treating dioxin-containing exhaust gas
01/10/2001EP0854899B1 Fluorine-substituted alkenyl liquid crystalline compounds
01/10/2001CN1279669A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
01/10/2001CN1279664A Process for preparing beta-ketoester fragrance pro-accords from 1,3-dioxan-4, 6-diones
01/09/2001US6172229 1-phenyl-4-benzylpiperazines; dopamine receptor subtype specific ligands
01/09/2001US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same
01/09/2001US6171522 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
01/09/2001CA2117483C [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors
01/04/2001WO2001000545A1 PRODUCTION OF OPTICALLY ACTIVE α-HYDROXYACETALS
01/03/2001EP1064275A1 Process for producing simvastatin and/or its derivatives
01/03/2001CN1060170C Method for purification of lactide
01/02/2001US6169085 A viricide for preventing and treating retroviral infection or the spread of a retrovirus, inhibiting replication of a retrovirus and treating aids
12/2000
12/27/2000CN1277962A Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
12/26/2000US6166065 2,3-dioxabicyclo[3.3.1]nonane derivatives and antimalarial pharmaceutical compositions comprising them
12/21/2000WO2000076957A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
12/20/2000EP1060175A2 Tryptase inhibitors
12/14/2000WO2000075099A1 Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
12/14/2000CA2339357A1 Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
12/12/2000US6160068 Monomer and a polymer obtained therefrom
12/07/2000WO2000073264A1 Cell proliferation inhibitors
12/07/2000WO2000073250A1 Treatment of a composition comprising a trimetlylohalkane bis-monolinear formal
12/07/2000DE10020061A1 Supertwist liquid crystal display includes a nematic liquid crystal mixture with different dielectric anisotropies
12/07/2000CA2371092A1 Cell proliferation inhibitors
12/06/2000EP1057826A1 Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them
12/06/2000EP1056741A1 Method for producing dimeric cyclic esters
12/06/2000EP1056740A1 Process for the production of optically enriched (r)- or (s)-albuterol
12/06/2000EP1056739A1 Novel cyclic pro-perfumes having modifiable fragrance raw material alcohol release rate
12/06/2000EP1056734A2 Substituted alxoxycarbonyl compounds
12/05/2000US6156905 Deoxy epothilones and intermediates utilized in the process for preparing epothilones
12/05/2000US6156429 Monomers with dilactone cycle, and corresponding polymers
11/2000
11/30/2000DE19924159A1 Preparation of alkene from acetylene and amino, hydroxyl or carboxyl compounds in the presence of cesium fluoride and alkali hydroxide catalyst
11/29/2000EP1055671A1 Process for producing simvastatin
11/29/2000EP0697017B1 Novel compounds for use in liquid-crystal compositions
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/28/2000US6153759 Herbicide comprising a 5-membered or 6-membered heterocyclic, saturated or unsaturated radical containing one to three hetero atoms selected from the group consisting of oxygen, sulfur and nitrogen
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/22/2000EP1053996A1 Ester compounds, liquid crystal compositions and liquid crystal display devices
11/22/2000CN1274356A Process for prepn. of optically active 2-(16-(hydroxymethyl)-1,3-dioxan-4-yl) acetic acid derivatives
11/22/2000CN1273967A Novel substituted dimeric compounds, its preparing process and medicinal compsns. containing same
11/21/2000US6150042 Material for organoelectro-luminescence device and use thereof
11/21/2000US6149838 Conjugated nitrile derivative, liquid crystal composition, and liquid crystal display elements
11/16/2000WO2000068221A1 Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
11/16/2000WO2000067751A1 Aryl amidines, compositions containing such compounds and methods of use
11/16/2000CA2373077A1 Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
11/16/2000CA2372496A1 Aryl amidines, compositions containing such compounds and methods of use
11/15/2000EP1052250A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/14/2000US6147117 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/14/2000CA2012432C N-(3-hydroxy-4piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives
11/09/2000WO2000066577A2 Brigded cycloalkanes as thromboxane ligands without blood clotting effects
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
11/08/2000EP1049667A1 Novel naphthyl substituted and heterocyclic substituted sulfonamides
11/08/2000EP1049666A1 Novel naphthyl-substituted and anilide-substituted sulfonamides
11/08/2000EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000EP0862550B1 Carboxylic acid derivatives, their preparation and their use
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/07/2000US6143790 Enzyme inhibitors
11/07/2000US6143747 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/07/2000US6143198 Liquid crystalline compounds having exo-methylene site and liquid crystal compositions comprising the same
11/07/2000CA2083913C Piperazinyl-and piperidinyl-cyclohexanols
11/02/2000EP1048665A1 Method for purifying lactide and lactide for food additives
11/02/2000EP1048640A1 Apoptosis inhibitors
11/02/2000EP1047656A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors
11/01/2000CN1271712A Fluoric diphenylacetylene compounds and preparing process and application thereof
10/2000
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140331 For treating anxiety disorders, depression, psychosis, impulse control disorders, alcohol abuse, ischaemic diseases, cardiovascular disorders, side effects induced by conventional antipsychotic agents and senile dementia
10/24/2000US6136225 Polymerizable liquid-crystalline compounds
10/19/2000WO2000061573A1 Novel benzodioxinones and method for obtaining same
10/17/2000US6133002 Acetalization of dialdehyde with alcohol, diol, or orthoformic ester; amination, cyanation, oxidation; enantioselective hydrolysis
10/17/2000US6132703 Cosmetic and pharmaceutical preparations containing photostable UV filters
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 103